Publication | Open Access

Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control

Neoadjuvant ChemoradiationSurgical OncologyRadiation TherapyGastrointestinal OncologyMedicineAdvanced Rectal CancerSurgeryCancer TreatmentPostoperative Adjuvant CapecitabineOncologyRadiation OncologyCancer Research